Chronic Hepatitis C: Peg-Interferon and /or ribavirin (PR) dose modifications during triple antiviral therapy have no impact on SVR rate: a single center experience
HEPATOLOGY(2013)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined